These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Free-living amebas of the genera Acanthamoeba and Naegleria: an overview and basic microbiologic correlates. Bottone EJ. Mt Sinai J Med; 1993 Sep; 60(4):260-70. PubMed ID: 8232368 [Abstract] [Full Text] [Related]
23. A rare but fatal case of granulomatous amebic encephalitis with brain abscess: the first case reported from Turkey. Sarica FB, Tufan K, Cekinmez M, Erdoğan B, Altinörs MN. Turk Neurosurg; 2009 Jul; 19(3):256-9. PubMed ID: 19621290 [Abstract] [Full Text] [Related]
27. Investigational drug available directly from CDC for the treatment of infections with free-living amebae. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2013 Aug 23; 62(33):666. PubMed ID: 23965830 [Abstract] [Full Text] [Related]
29. "Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae". Baig AM. Infect Disord Drug Targets; 2020 Aug 23; 20(2):115-121. PubMed ID: 30961516 [Abstract] [Full Text] [Related]
30. Infections with free-living amebae. Visvesvara GS. Handb Clin Neurol; 2013 Aug 23; 114():153-68. PubMed ID: 23829906 [Abstract] [Full Text] [Related]
32. CNS infections with free-living amebas: neuroimaging findings. Kidney DD, Kim SH. AJR Am J Roentgenol; 1998 Sep 23; 171(3):809-12. PubMed ID: 9725321 [Abstract] [Full Text] [Related]
33. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response? Baig AM. Acta Trop; 2015 Aug 23; 148():72-6. PubMed ID: 25930186 [Abstract] [Full Text] [Related]
34. Amphizoic amoebae: pathogenic free-living protozoa; review of the literature and review of cases in Thailand. Siripanth C. J Med Assoc Thai; 2005 May 23; 88(5):701-7. PubMed ID: 16149694 [Abstract] [Full Text] [Related]
36. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru. Cabello-Vílchez AM, Martín-Navarro CM, López-Arencibia A, Reyes-Batlle M, Sifaoui I, Valladares B, Piñero JE, Lorenzo-Morales J. Parasitol Res; 2014 Feb 23; 113(2):755-9. PubMed ID: 24265059 [Abstract] [Full Text] [Related]
37. In vitro effect of artesunate against Acanthamoeba spp. Nacapunchai D, Phadungkul K, Kaewcharus S. Southeast Asian J Trop Med Public Health; 2002 Feb 23; 33 Suppl 3():49-52. PubMed ID: 12971474 [Abstract] [Full Text] [Related]
38. Screening Swiss water bodies for potentially pathogenic free-living amoebae. Gianinazzi C, Schild M, Wüthrich F, Ben Nouir N, Füchslin HP, Schürch N, Gottstein B, Müller N. Res Microbiol; 2009 Feb 23; 160(6):367-74. PubMed ID: 19589386 [Abstract] [Full Text] [Related]
39. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures. Siddiqui R, Boghossian A, Alqassim SS, Kawish M, Gul J, Jabri T, Shah MR, Khan NA. Arch Microbiol; 2023 Apr 05; 205(5):170. PubMed ID: 37017767 [Abstract] [Full Text] [Related]
40. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri. Kim JH, Lee YJ, Sohn HJ, Song KJ, Kwon D, Kwon MH, Im KI, Shin HJ. Int J Antimicrob Agents; 2008 Nov 05; 32(5):411-7. PubMed ID: 18762406 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]